Pain medication, resiniferatoxin, may increase sepsis-related mortality

Pain researchers have discovered that resiniferatoxin, a drug that has shown early promise as an option for chronic, severe pain sufferers, may decrease the body’s ability to fight off bacterial infections, particularly sepsis.